RePORT International Resources

In 1974, the US National Research Act was signed into law, there-by creating the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. One of the charges to the Commission was to identify the basic ethical principles that should underlie the conduct of biomedical and behavioral research involving human subjects and to develop guidelines which should be followed to assure that such research is conducted in accordance with those principles. In carrying out the above, the Commission was directed to consider: (i) the boundaries between biomedical and behavioral research and the accepted and routine practice of medicine, (ii) the role of assessment of risk-benefit criteria in the determination of the appropriateness of research involving human subjects, (iii) appropriate guidelines for the selection of human subjects for participation in such research and (iv) the nature and definition of informed consent in various research settings. The Belmont Report attempts to summarize the basic ethical principles identified by the Commission in the course of its deliberations.

This Crash Course video, The Deadliest Infectious Disease of All Time, explores the history, biology, and global impact of TB. From its ancient origins to its ongoing role as a leading cause of infectious death worldwide, the video examines how TB spreads, why it remains so deadly, and how social and political factors shape its burden. Engaging and informative, the episode highlights both scientific advances and enduring health inequities.

The conference will be June 8-11, 2026, in Boksburg, Gauteng. The conference experience begins even before the formal programme opens, with pre-conference satellite sessions and continues beyond the core programme through additional satellite sessions and policy roundtables. These half- and full-day engagements are practical, focused, and skills-oriented, enabling delegates to deepen their expertise, engage directly with leading TB practitioners, and explore tools, methods, and implementation strategies applicable to policy, practice, and research. Collectively, these sessions provide space for in-depth discussion on priority issues, innovations, and regional contexts, fostering targeted dialogue, strategic alignment, and collaborative problem-solving among researchers, policymakers, donors, and implementers.

APPLICATION DEADLINE: May 27, 2026 The Global Forum on Bioethics in Research (GFBR) will hold a two-day meeting in November 2026 on the topic ‘Digital footprints and real-time data in the context of health research: ethical issues’ (dates and location to be confirmed). Provisional dates are 17-18 November. The topic scope is described in the Forum background paper. As part of the upcoming meeting, the GFBR is looking for four types of presentation proposals: 1. Real-life case studies that explore ethical dimensions of health research using digital footprints. 2. Conceptual papers that define, clarify, and analyse key moral terms to address ethical dimensions of using digital footprints and real-time data for human health research. 3. Normative papers that provide in-depth ethical analysis or explore unresolved ethical questions related to the use of digital footprints and real-time data in health research. 4. Policy-related papers that address ethical issues that arise from governance or policy matters related to the topic or explore the translation of ethics and value-based decision-making into policy. The background paper provides more details on each type of proposal. We particularly welcome proposals that address the key theme and questions highlighted in the paper, which have been prioritised by the Forum Planning Committee. The GFBR is also seeking participants to attend the meeting, with places awarded on a competitive basis. Awards are available for successful applicants from low- and middle-income countries to cover the cost of their travel, accommodation and single-entry visa. See the GFBR website for details on how to apply online.

The 2025 Results Report is a snapshot of the partnerships' progress in the fight to end AIDS, TB and malaria during 2024.

The Global Health Network aims to strengthen health research in underserved areas by: Supporting and streamlining research where evidence is lacking. Promoting equity in participation and access to research benefits through open sharing of knowledge and data. Building sustainable, skilled research teams in low-resource settings capable of leading and competing globally.

New course - free and online - An Introduction and Practical Guide to Community Engagement and Involvement in Global Health Research

Good Clinical Laboratory Practice (GCLP) is a set of guidelines describing the application of those Good Laboratory Practice principles that are relevant to the analyses of samples from clinical trials while ensuring the purpose and objectives of the Good Clinical Practice principles are maintained. In so doing, the reliability, quality, consistency and integrity of data generated by clinical trial laboratories can be assure which is crucial to the outcome of any clinical trial.

This ICH E6 GCP Investigator Site Training, in multiple languages, meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.

New course - free and online - Research Ethics Online Training (V2)

The templates have been shared by groups, and are free to use and adapt for individual's research studies.

Our research team is accepting applications for a postdoctoral fellowship based in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health under the mentorship of Dr. David Dowdy and Dr. Emily Kendall. The start date for these fellowships is flexible, but preference will be given to applicants who can start by June 2026. According to JHU policy, appointments will be for one year, renewable by mutual agreement – our hope is to recruit a fellow who is interested in a two-year fellowship. We are seeking fellows with a background in mathematical modeling and cost-effectiveness analysis, and interest in combining these tools with both primary and secondary data sources to answer policy-relevant questions about tuberculosis interventions. Reflecting our team-based, collaborative approach to research, fellows will work with a broader mentorship team, with additional mentors drawn from the Center for Tuberculosis Research and other collaborating teams as appropriate. This fellowship will be funded from a combination of four specific projects (described below), providing flexibility to structure the fellowship around the goals of individual applicants. Successful fellows will help broaden our team’s horizons, enabling us to build new collaborations and explore new research areas. The specific deliverables for this fellowship are linked to ongoing field-based studies with empiric data collection, including: . Models of the impact and cost-effectiveness of school-based screening and prevention in India. Estimating the long-term impact and cost-effectiveness of school-based TB disease screening, with or without the addition of preventive therapy for people with infection . Models of the impact and cost-effectiveness of venue-targeted vaccination programs in Zambia, Nigeria, and Indonesia. Evaluating whether vaccination is more efficient when delivered at specific venues (e.g., prisons, mines, bars) than to the general population or at health facilities . Models of the impact and cost-effectiveness of novel diagnostic assays for tuberculosis. Understanding the importance of different design characteristics and implementation strategies for novel diagnostics, particularly those intended for children, screening, and/or drug susceptibility testing . Models of the impact and cost-effectiveness of drug susceptibility testing for bedaquiline. Forecasting the future and health impact of bedaquiline-resistant TB under different scenarios of availability and scale-up of drug susceptibility testing in key countries Applicants must have: . A recent PhD (or MD) degree in a relevant discipline (expected graduation in Spring 2026 is acceptable). . Strong quantitative background, with demonstrated ability to program in one or more scientific programming languages, e.g. R, Python, C++, etc. . Demonstrated ability to lead modeling research, as well as strong communication and writing skills. . Ability to work independently, function as part of a highly collaborative, interdisciplinary, open-source-oriented team, and contribute to biweekly team meetings and journal clubs. Application Procedures Interested applicants should submit the following via a single email to Dr. Dowdy (ddowdy1@jhmi.edu): - Cover letter describing research interests, career goals, and prior experience - Curriculum vitae - Contact information of 3 references (to be contacted only after first discussing with the applicant) Applications submitted by January 31 will be given priority. Initial interviews will be held in Feb 2025 and selections made promptly. We encourage applications regardless of precise timeline or current location, and we will work with qualified candidates to sort out hiring details and timelines. Please contact Dr. Dowdy and/or Dr. Kendall (ekendall@jhmi.edu) by email with any questions.

DEADLINE: January 2026 SEPTRE (SPIRIT Electronic Protocol Tool and Resource) is an innovative, web-based software solution that makes it easier to create, manage, and register high-quality protocols for clinical trials. From now until January 2026, The Global Health Network and EDCTP have a limited number of free individual three-year SEPTRE licenses for researchers based in low-resource settings.

the World Health Organization (WHO) has published the WHO/GLI TB Near point-of-care and swab-based testing toolkit (NPOC/Swab Toolkit) in collaboration with the Stop TB Partnership Global Laboratory Initiative. The NPOC/Swab Toolkit includes a comprehensive set of tools to support implementation of TB near point-of-care nucleic acid amplification tests (NPOC-NAATs) for swabs of sputum and tongue swabs to diagnose tuberculosis (TB) with and without drug resistance. Toolkit materials can be accessed in this website.

This course catalogue 2026 launched by The Union for features a wide range of free online learning opportunities designed to support your professional growth.

The "Atlas of TB Innovations" is catalogue of all innovations in the fight against Tuberculosis (TB). Innovations showcases cutting-edge solutions, breakthrough technologies and transformative ideas that drive progress. Explore advancements shaping the future across various industries.

The PHA Editors will consider any manuscript reporting original research on progress to achieving the SDGs. Suitable topics include infection-related topics such as vaccines, infection prevention control, outbreaks and antimicrobial resistance. Non-communicable diseases of public health importance include nutrition, the impact of climate change and planetary health. The journal aims to improve public health practice and we welcome operational research, lessons from implementation and evaluations of public health interventions. We will also consider submissions that focus on issues related to health care access and universal health coverage, quality, efficiency, cost-effectiveness, ethics and equity as well as education and training.

In-person courses and virtual options, too - Free online courses We currently offer the following online courses, free of charge: How to develop a research grant proposal (English) Interpretation of CXR in children with presumptive TB (English) Interpretation of CXR in adults (French) Prevent TB: management of TB infection (English, French and Spanish)

You must first log in to the Union site to access these courses.